52Y-27990-79044
5 vaccinations
16 coded responses
35 check-ins
15 free-text entries
5 call cases
- Sex
- Female
- Age at first dose
- 66+
- ZIP prefix
- 490 / MI
- Registered
- 2021-01-22
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-22
Registered in v-safe
-
2021-01-22
Dose 1 — Pfizer-BioNTech
-
2021-01-22
Survey response — day 0, dose 1MedDRA: Dry throat — Feeling: Fair · Site: Pain · Muscle or body achesFree text: Raspy throatMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-23
- 2021-01-24
- 2021-01-25
- 2021-01-26
- 2021-01-27
- 2021-01-28
- 2021-01-29
- 2021-02-05
-
2021-02-12
Dose 2 — Pfizer-BioNTech
-
2021-02-14
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Joint pains, Muscle or body achesAdult check-in
-
2021-02-15
Survey response — days 1–6 daily, dose 2MedDRA: Blood glucose increased, Pain, Type 1 diabetes mellitus — Feeling: Good · Fever · Muscle or body achesFree text: High blood sugars. Type 1 body aches first 2 daysMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-16
Survey response — days 1–6 daily, dose 2MedDRA: Blood glucose abnormal — Feeling: GoodFree text: Bs still highMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-17
-
2021-02-18
Survey response — days 1–6 daily, dose 2MedDRA: Oropharyngeal pain — Feeling: Good · Muscle or body achesFree text: Sore throatMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-20
Survey response — day 7, dose 2MedDRA: Unevaluable event — Feeling: GoodFree text: Blood sugars are back to normalMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-26
Survey response — day 14, dose 2MedDRA: Rhinorrhoea — Feeling: GoodFree text: Runny noseMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-05
-
2021-03-12
Survey response — day 28, dose 2MedDRA: Fatigue, Respiratory disorder — Feeling: FairFree text: Tired breathing problemsMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-19
Survey response — day 35, dose 2MedDRA: Dyspnoea exertional — Feeling: GoodFree text: Still have problems with breath during exerciseMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-26
-
2021-05-14
Survey response — 3 months, dose 2MedDRA: Hyperventilation, Office visit — Feeling: Good · Get care from a doctor or other healthcare professionalFree text: Symptoms: Still having breathing issues. May or may not be related · Healthcare visit (other): Office visitsMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-05-14
Report sent to call center — 3 months, dose 2Get care from a doctor or other healthcare professional1 call case(s)
- 2021-08-13
-
2021-08-21
Dose 3 — Pfizer-BioNTech
-
2021-10-01
Survey response — day 35, dose 3MedDRA: Respiratory disorder — Feeling: GoodFree text: Breathing problemsMedDRA releases: 2024-11 · check-in free text available
- 2021-10-02
-
2021-11-20
Survey response — 3 months, dose 3MedDRA: Respiratory disorder — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Still having breathing problemsMedDRA releases: 2024-11 · check-in free text available
-
2021-11-20
Report sent to call center — 3 months, dose 3Be unable to do your normal daily activities · Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2021-11-23
-
2021-11-30
Call successfulParticipant prefers to complete VAERS report online
-
2021-11-30
Call successfulParticipant prefers to complete VAERS report online
- 2022-02-19
-
2022-04-04
Dose 4 — Pfizer-BioNTech
- 2022-04-14
-
2022-04-18
Survey response — day 14, dose 4MedDRA: Lung disorder, Respiratory disorder — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Lung and breathing seems worseMedDRA releases: 2024-11 · check-in free text available
-
2022-04-25
Survey response — day 21, dose 4MedDRA: Respiratory disorder, Unevaluable event — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professionalFree text: Symptoms: Breathing issues · Healthcare visit (other): Going to have clinicMedDRA releases: 2024-11 · check-in free text available
-
2022-04-25
Report sent to call center — day 21, dose 4Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
- 2022-04-26
-
2022-05-02
Survey response — day 28, dose 4MedDRA: Respiratory disorder — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Breathing issuesMedDRA releases: 2024-11 · check-in free text available
- 2022-05-03
-
2022-05-03
Call successfulCompleted over the phone
- 2022-05-09
- 2022-05-16
- 2022-07-04
-
2022-09-16
Dose 5 — Moderna
-
2022-10-03
Survey response — 6 months, dose 4MedDRA: Dysphonia, Herpes zoster, Office visit — Feeling: Fair · Get care from a doctor or other healthcare professionalFree text: Symptoms: Funny squeaky voice now and then. Have had shingles. · Healthcare visit (other): Urgent care and drs officeMedDRA releases: 2024-11 · check-in free text available
-
2022-10-03
Report sent to call center — 6 months, dose 4Get care from a doctor or other healthcare professional1 call case(s)
- 2022-10-04
- 2022-10-06
-
2022-10-06
Callback requested for03:00PM ET
-
2022-10-06
Call successfulCompleted over the phone
-
2023-04-04
Survey response — 12 months, dose 4MedDRA: COVID-19 — Feeling: Good · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationMedDRA releases: 2024-11
-
2023-04-04
Report sent to call center — 12 months, dose 4Be unable to do your normal daily activities · Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2023-04-05
-
2023-04-05
Call successfulCompleted over the phone
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-22 | Pfizer-BioNTech | |
| 2 | 2021-02-12 | Pfizer-BioNTech | |
| 3 | 2021-08-21 | Pfizer-BioNTech | No |
| 4 | 2022-04-04 | Pfizer-BioNTech | No |
| 5 | 2022-09-16 | Moderna | No |
Call center
5 call center cases
5 successful
VAERS report filed, before or during a call: 3
Free text
Release 2 — day 0, dose 1
Systemic reaction (other): Raspy throat
Release 4 — days 1–6 daily, dose 2
Systemic reaction (other): High blood sugars. Type 1 body aches first 2 days
Systemic reaction (other): Bs still high
Systemic reaction (other): Sore throat
Release 4 — day 7, dose 2
Systemic reaction (other): Blood sugars are back to normal
Release 4 — day 14, dose 2
Symptoms: Runny nose
Release 5 — day 28, dose 2
Symptoms: Tired breathing problems
Release 5 — day 35, dose 2
Symptoms: Still have problems with breath during exercise
Release 8 — 3 months, dose 2
Symptoms: Still having breathing issues. May or may not be related
Healthcare visit (other): Office visits
Release 9 — day 35, dose 3
Symptoms: Breathing problems
Release 10 — 3 months, dose 3
Symptoms: Still having breathing problems
Release 11 — day 14, dose 4
Symptoms: Lung and breathing seems worse
Release 11 — day 21, dose 4
Release 11 — day 28, dose 4
Symptoms: Breathing issues
Release 12 — 6 months, dose 4
Symptoms: Funny squeaky voice now and then. Have had shingles.
Healthcare visit (other): Urgent care and drs office
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Office visit | ✓ | ✓ | ✓ |
| HCVO | Unevaluable event | · | · | ✓ |
| SD | COVID-19 | · | · | ✓ |
| SD | Dysphonia | · | · | ✓ |
| SD | Dyspnoea exertional | ✓ | ✓ | ✓ |
| SD | Fatigue | ✓ | ✓ | ✓ |
| SD | Herpes zoster | · | · | ✓ |
| SD | Hyperventilation | ✓ | ✓ | ✓ |
| SD | Lung disorder | · | · | ✓ |
| SD | Respiratory disorder | ✓ | ✓ | ✓ |
| SD | Rhinorrhoea | ✓ | ✓ | ✓ |
| SRO | Blood glucose abnormal | ✓ | ✓ | ✓ |
| SRO | Blood glucose increased | ✓ | ✓ | ✓ |
| SRO | Dry throat | ✓ | ✓ | ✓ |
| SRO | Oropharyngeal pain | ✓ | ✓ | ✓ |
| SRO | Pain | ✓ | ✓ | ✓ |
| SRO | Type 1 diabetes mellitus | ✓ | ✓ | ✓ |
| SRO | Unevaluable event | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release